[Close]
This page was created by volunteers like you!
Help us make it even better. To learn more about contributing to MEpedia, click here.
Join the movement
Visit #MEAction to find support or take action. Donate today to help us improve and expand this project.
Congratulations!
MEpedia has got over 30 million views as of August 2022!

Colchicine

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history

Colchicine is an anti-inflammatory that also acts as an immunomodulator and is used for a number of different illnesses including gout, recurrent pericarditis, and familial Mediterranean fever.[1][2][3] Colchicine is also sold under the brand names Colcrys, Mitigare, Gloperba.[3]

Theory[edit | edit source]

Evidence[edit | edit source]

Clinicians[edit | edit source]

Risks and safety[edit | edit source]

Costs and availability[edit | edit source]

See also[edit | edit source]

Learn more[edit | edit source]

References[edit | edit source]

  1. ↑ "Colchicine | COVID-19 Treatment Guidelines". National Institutes of Health. Retrieved January 3, 2022.
  2. ↑ "Colchicine". drugs.com. Retrieved January 3, 2022.
  3. ↑ Jump up to: 3.0 3.1 "Colchicine: MedlinePlus Drug Information". MedlinePlus. Retrieved January 3, 2022.

An immunomodulator is a substance that affects the functioning of the immune system[1]

immunomodulator An immunomodulator is a substance that affects the functioning of the immune system

See National Institutes of Health.

National Institutes of Health (NIH) - A set of biomedical research institutes operated by the U.S. government, under the auspices of the Department of Health and Human Services.

Retrieved from "https://me-pedia.org/w/index.php?title=Colchicine&oldid=237484"